Drug Pipeline

Telmisartan Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
5
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 2
2
Phase 1/2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07547878 Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) Chronic Kidney Disease Not Yet Recruiting
Phase 2
NCT06815497 Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer Ovarian Cancer Recruiting
NCT06483789 Efficacy and Safety of HB-1 for Panic Disorder Panic Disorder Recruiting
Phase 1/2
NCT07370506 Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients Breast Cancer Not Yet Recruiting
Not specified
NCT07568574 Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes Enrolling by Invitation
Sponsors Running Telmisartan Trials
Disease Areas
Get alerts when Telmisartan trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free